Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | $5.02B |
| FY2019, ended Dec 31, 2019 | $7.21B |
| FY2020, ended Dec 31, 2020 | $41.8B |
| FY2021, ended Dec 31, 2021 | $102B |
| FY2022, ended Dec 31, 2022 | $69.4B |
| FY2023, ended Dec 31, 2023 | $38.0B |
| FY2024, ended Dec 31, 2024 | $16.0B |
| FY2025, ended Dec 31, 2025 | $11.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $28.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $108M |
| FY2017, ended Dec 31, 2017 | $206M |
| FY2018, ended Dec 31, 2018 | $135M |
| FY2019, ended Dec 31, 2019 | $60.2M |
| FY2020, ended Dec 31, 2020 | $803M |
| FY2021, ended Dec 31, 2021 | $18.5B |
| FY2022, ended Dec 31, 2022 | $19.3B |
| FY2023, ended Dec 31, 2023 | $6.85B |
| FY2024, ended Dec 31, 2024 | $3.24B |
| FY2025, ended Dec 31, 2025 | $1.94B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.23B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$216M | $33.6M |
| FY2017, ended Dec 31, 2017 | −$256M | −$390M |
| FY2018, ended Dec 31, 2018 | −$385M | −$437M |
| FY2019, ended Dec 31, 2019 | −$514M | −$491M |
| FY2020, ended Dec 31, 2020 | −$747M | $1.96B |
| FY2021, ended Dec 31, 2021 | $12.2B | $13.3B |
| FY2022, ended Dec 31, 2022 | $8.36B | $4.58B |
| FY2023, ended Dec 31, 2023 | −$4.71B | −$3.83B |
| FY2024, ended Dec 31, 2024 | −$3.56B | −$4.05B |
| FY2025, ended Dec 31, 2025 | −$2.82B | −$2.06B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | −$3.15B | −$1.24B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $50.1M |
| FY2017, ended Dec 31, 2017 | $135M |
| FY2018, ended Dec 31, 2018 | $658M |
| FY2019, ended Dec 31, 2019 | $236M |
| FY2020, ended Dec 31, 2020 | $2.62B |
| FY2021, ended Dec 31, 2021 | $6.85B |
| FY2022, ended Dec 31, 2022 | $3.21B |
| FY2023, ended Dec 31, 2023 | $2.91B |
| FY2024, ended Dec 31, 2024 | $1.93B |
| FY2025, ended Dec 31, 2025 | $2.60B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.72B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | — |
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | $0 |
| FY2025, ended Dec 31, 2025 | $590M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $591M |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 557% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 60.7M |
| FY2017, ended Dec 31, 2017 | 65.2M |
| FY2018, ended Dec 31, 2018 | 329M |
| FY2019, ended Dec 31, 2019 | 369M |
| FY2020, ended Dec 31, 2020 | 400M |
| FY2021, ended Dec 31, 2021 | 403M |
| FY2022, ended Dec 31, 2022 | 386M |
| FY2023, ended Dec 31, 2023 | 382M |
| FY2024, ended Dec 31, 2024 | 386M |
| FY2025, ended Dec 31, 2025 | 395M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 399M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $39.4M | — |
| FY2017, ended Dec 31, 2017 | — | $40.1M | — |
| FY2018, ended Dec 31, 2018 | — | $72.6M | $563M |
| FY2019, ended Dec 31, 2019 | $0 | $81.0M | $0 |
| FY2020, ended Dec 31, 2020 | $0 | $93.0M | $1.85B |
| FY2021, ended Dec 31, 2021 | $857M | $142M | $0 |
| FY2022, ended Dec 31, 2022 | $3.33B | $226M | $0 |
| FY2023, ended Dec 31, 2023 | $1.15B | $305M | — |
| FY2024, ended Dec 31, 2024 | $0 | $429M | — |
| FY2025, ended Dec 31, 2025 | $2.00M | $483M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $462M | — |
Valuation
At current price- Market Cap
- $83.0B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 37.3×
- Price / Book
- 12.3×
- EV / EBITDA
- n/m. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $2.23B
- Revenue Growth YoY
- −27.6%
- Revenue CAGR 3Y
- −53.4%
- Revenue CAGR 5Y
- 19.3%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 23.4%
- Operating Margin
- −149%
- Net Margin
- −141%
- FCF Margin
- −55.8%
- Return on Equity
- −39.0%
Earnings
Trailing 12 months- Net Income
- −$3.15B
- EPS (diluted)
- −$7.98
- EBITDA
- −$3.09B
- Operating Income
- −$3.32B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.72B
- Total Debt
- $591M
- Net Cash
- $1.13B
- Total Assets
- $11.0B
- Total Liabilities
- $4.20B
- Shareholders' Equity
- $6.76B
Cash Flow
Trailing 12 months- Operating Cash Flow
- −$1.07B
- Capital Expenditure
- $171M
- Free Cash Flow
- −$1.24B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.09
Every ratio is calculated from the company’s reported figures.